Tag: biomedical
-

Infographic – U.S. Public Divided on Contact Tracking
A survey by the Washington Post and University of Maryland released this week indicates the proposed app is getting a lukewarm reception at best.
-

Stroke Found in More Young Adult Covid-19 Patients
An analysis of medical records shows individuals age 30 to 50 with Covid-19 infections are more likely to experience a stroke than their non-infected counterparts.
-

Trial Tests Blood Pressure Drug as Covid-19 Treatment
A common type of blood pressure drug will soon be tested in a clinical trial as a treatment for severe cases of Covid-19 infections.
-

NIH Opens Covid-19 Diagnostic Test Challenge
National Institutes of Health began a competition for new diagnostic tests that can better determine the extent of Covid-19 infections in the U.S.
-

Oxford, AstraZeneca Partner on Covid-19 Vaccine
AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford.
-

Blood Test Detects Multiple Early Cancers
A clinical trial enrolling some 10,000 women demonstrates the feasibility of a routine blood test to screen for multiple types of cancer in their early stages.
-

Trial to Test Many Covid-19 Lung Disease Treatments
A clinical trial designed to make quick changes to accommodate new conditions plans to assess 10 to 20 drugs for a serious lung complication from Covid-19 infections.
-

Univ Building Single Covid-19 Diagnostic, Antibody Test
A university bio-engineering lab is developing a single point-of-care test that detects both Covid-19 viruses in nasal swabs and antibodies in blood samples.
-

Limited Covid-19 Benefits Found for Arthritis Drug
A clinical trial testing an arthritis drug to treat Covid-19 patients shows the drug helps the most critical patients, but not others with advanced infections.
-

Psychiatric Drug Maker Raises $80M in Venture Funds
A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing.